A

AbbVie Inc. (ABBV)

NYQ – Real Time Price. Currency in USD

284.75

-0.05 (-0.02%)

Market open: Oct 22, 2026, 2:55 PM EDT

Get all premium features to the best stock analysis tool

Finranks

Contact us

[email protected]

AbbVie Inc. (ABBV)

NYQ – Real Time Price. Currency in USD

284.75

-0.05 (-0.02%)

Market open: Oct 22, 2026, 2:55 PM EDT

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

61.16B

56.33B

54.32B

58.05B

Cost of goods sold

-18.27B

-16.83B

-16.65B

-16.45B

Gross Profit

42.89B

39.50B

37.67B

41.61B

Operating expenses (excl. COGS)

-21.98B

-22.88B

-19.59B

-19.01B

Operating Income

20.91B

16.63B

18.08B

22.60B

Non-operating income, total

-14.32B

-12.91B

-11.83B

-9.13B

Pretax income

6.60B

3.72B

6.25B

13.48B

Equity in earnings

0

Taxes

-2.36B

570M

-1.38B

-1.63B

Non-controlling/minority interest

-7M

-8M

-10M

-9M

After tax other income/expense

-40M

-43M

-54M

Net income before discontinued operations

4.19B

4.24B

4.82B

11.78B

Discontinued operations

0

Net income

4.19B

4.24B

4.82B

11.78B

Dilution adjustment

0

Preferred dividends

0

Search stocks

AbbVie Inc. (ABBV)

Get all premium features to the best stock analysis tool

Finranks

Contact us

Follow us

AbbVie Inc. (ABBV)

Income Statement (Annual)